Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race?

Vascular Medicine

Volumn 11, Issue 1, 2006, Pages 13-20

  Iribarren, Carlos ^a   Herrinton, Lisa J ^a   Darbinian, Jeanne A ^a   Tamarkin, Lawrence ^b   Malinowski, Donald ^b   Vogelman, Joseph H ^c   Orentreich, Norman ^c   Baer, David ^d  

^a DIVISION OF RESEARCH   (United States)

^b CytImmune Sciences Inc   (United States)

^c Orentreich Foundation for the Advancement of Science Inc   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

Angiogenesis; Epidemiology; Myocardial infarction

Indexed keywords

ENDOSTATIN;

ACUTE HEART INFARCTION; ADULT; AGE; ANGIOGENESIS; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY RISK; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NEGRO; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AFRICAN AMERICANS; ASIAN AMERICANS; CALIFORNIA; CASE-CONTROL STUDIES; ENDOSTATINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING;

EID: 33646164164     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x06vm654oa     Document Type: Article

References (25)

1. Kuwano M, Fukushi J, Okamoto M, Nishie A, Goto H, Ishibashi T, Ono M. Angiogenesis factors. Intern Med 2001; 40: 565-72.
2. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004; 26: 943-54.
3. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Schwartz SM. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994; 145: 883-94.
4. Tenaglia AN, Peters KG, Sketch MH Jr, Annex BH. Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. Am Heart J 1998; 135: 10-14.
5. Nakajima K, Tabata S, Yamashita T, Kusuhara M, Arakawa K, Ohmori R, Yonemura A, Higashi K, Ayaori M, Nakamura H, Ohsuzu F. Plasma vascular endothelial growth factor level is elevated in patients with multivessel coronary artery disease. Clin Cardiol 2004; 27: 281-86.
6. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-85.
7. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin and TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999; 99: 1726-32.
8. Seko Y, Fukuda S, Nagai R. Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy. Clin Sci 2004; 106: 439-42.
9. Collen MF ed. Multiphasic health testing services. John Wiley & Sons, 1978
10. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992; 82: 703-10.
11. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA 2002; 287: 2519-27.
12. Abell LL, Levy BB, Brodie BB, Kendall FE. Simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952; 195: 357-66.
13. Hao X, Mansson-Broberg A, Blomberg P, Dellgren G, Siddiqui AJ, Grinnemo KH, Wardell E, Sylven C. Angiogenic and cardiac functional effects of dual gene transfer of VEGF-A165 and PDGF-BB after myocardial infarction. Biochem Biophys Res Commun 2004; 322: 292-96.
14. Emanueli C, Madeddu P. Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseases. Arch Mal Coeur Vaiss 2004; 97: 679-87.
15. Zorick TS, Mustacchi Z, Bando SY, Zatz M, Moreira-Filho CA, Olsen B, Passos-Bueno MR. High serum endostatin levels in Down's syndrome: implications for improved treatment and prevention of solid tumours. Eur J Hum Genet 2001; 9: 811-14.
16. Murdoch JC, Rodger JC, Rao SS, Fletcher CD, Dunnigan MG. Down's syndrome: an atheroma-free model? Br Med J 1977; ii: 226-28.
17. Yla-Herttuala S, Luoma J, Nikkari T, Kivimaki T. Down's syndrome and atherosclerosis. Atherosclerosis 1989; 76: 269-72.
18. Pueschel SM, Craig WY, Haddow JE. Lipids and lipoproteins in persons with Down's syndrome. J Intellect Disabil Res 1992; 36: 365-69.
19. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002; 359: 1019-25.
20. Ren B, Wang Y, Rabasseda X, Wang YZ. Recombinant human endostatin is beneficial to endothelial cell growth exposed to mildly oxidized low-density lipoproteins. Methods Find Exp Clin Pharmacol 2002; 24: 195-99.
21. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 2002; 99: 10730-35.
22. Reijerkerk A, Mosnier LO, Kranenburg O, Bouma BN, Carmeliet P, Drixler T, Meijers JC, Voest EE, Gebbink MF. Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system. Mol Cancer Res 2003; 1: 561-68.
23. Moulton KS, Olsen BR, Sonn S, Fukai N, Zurakowski D, Zeng X. Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation 2004; 110: 1330-36.
24. Friedman GD, Blaner WS, Goodman DS, Vogelman JH, Brind JL, Hoover R, Fireman BH, Orentreich N. Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. Am J Epidemiol 1986; 123: 781-89.
25. Matsunaga T, Chilian WM, March K. Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease. Am J Physiol Heart Circ Physiol 2005; 288: 2042-46.